Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Seneca Global Income & Grwth

29 Nov 2016 12:02

RNS Number : 4461Q
Seneca Global Income & Growth PLC
29 November 2016
 

 

London, UK, 29 November 2016

Edison issues research review on Seneca Global Income & Growth Trust (SIGT)

 

Seneca Global Income & Growth Trust (SIGT) aims to generate income and long-term capital growth from a range of asset classes. Investments are made for the long term using a strategic asset allocation to equities (60%: 35% UK and 25% overseas, with modest US exposure), fixed income (15%) and specialist assets (25%, including property and infrastructure assets, where yields can be in the 5-8% range). Around one-third of the fund is invested in UK mid-caps, where over time returns tend to be higher than for large-caps, and where the market is generally less efficient, providing opportunities for stock picking. There is no exposure to safe-haven government bonds, which the managers consider unattractively valued, and SIGT has lower FX exposure than its peers. Following a change in investment mandate in 2012, SIGT's NAV total return has meaningfully outperformed the FTSE All-Share index, with significantly lower volatility.

 

SIGT's current 1.8% share price premium to cum-income NAV compares to the average 0.6% premium of the last 12 months and the average discounts of the last three, five and 10 years (3.2%, 6.4% and 7.2%, respectively). While SIGT has no formal income target, the board states that it wants to pursue a progressive dividend policy. The annual dividend has been increased each year since 2013; the prospective dividend yield is 3.8%.

Click here to view the full report

 

All reports published by Edison are available to download free of charge from its website: www.edisoninvestmentresearch.com

 

About Edison: Edison is an international equity research firm with a team of over 70 analysts, investment and roadshow professionals and works with both large and smaller capitalised companies, blue chip institutional investors, wealth managers, private equity and corporate finance houses to support their capital markets activity. Edison provides services to more than 420 retained corporate and investor clients from offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority.

 

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

Contact details: Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn

www.linkedin.com/company/edison-investment-research

Twitter

www.twitter.com/Edison_Inv_Res

YouTube

www.youtube.com/edisonitv

Google+

https://plus.google.com/105425025202328783163/posts

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKLFLQFFEFBV
Date   Source Headline
31st Dec 202012:58 pmRNSNet Asset Value(s)
30th Dec 20201:32 pmRNSNet Asset Value(s)
29th Dec 202012:57 pmRNSNet Asset Value(s)
24th Dec 202011:31 amRNSNet Asset Value(s)
23rd Dec 20205:41 pmRNSTransaction in Own Shares
23rd Dec 202011:02 amRNSNet Asset Value(s)
22nd Dec 202012:21 pmRNSNet Asset Value(s)
22nd Dec 202010:25 amRNSResult of General Meeting
21st Dec 20204:57 pmRNSTransaction in Own Shares
21st Dec 202012:27 pmRNSNet Asset Value(s)
21st Dec 202011:14 amRNSBlock listing Interim Review
18th Dec 202012:07 pmRNSNet Asset Value(s)
17th Dec 20201:52 pmRNSNet Asset Value(s)
16th Dec 20201:10 pmRNSNet Asset Value(s)
15th Dec 20205:11 pmRNSTransaction in Own Shares
15th Dec 20201:05 pmRNSNet Asset Value(s)
14th Dec 20201:17 pmRNSNet Asset Value(s)
11th Dec 202012:38 pmRNSNet Asset Value(s)
10th Dec 20204:18 pmRNSNet Asset Value(s)
9th Dec 202011:17 amRNSNet Asset Value(s)
8th Dec 202011:14 amRNSNet Asset Value(s)
7th Dec 202012:29 pmRNSNet Asset Value(s)
4th Dec 202011:15 amRNSNet Asset Value(s)
3rd Dec 202012:51 pmRNSNet Asset Value(s)
2nd Dec 202011:34 amRNSNet Asset Value(s)
2nd Dec 202010:31 amRNSResults analysis from Kepler Trust Intelligence
2nd Dec 20207:00 amRNSCirc re. General Meeting
2nd Dec 20207:00 amRNSHalf-year Report
1st Dec 202012:19 pmRNSNet Asset Value(s)
1st Dec 202012:01 pmRNSTotal Voting Rights
30th Nov 202012:09 pmRNSNet Asset Value(s)
27th Nov 202010:55 amRNSNet Asset Value(s)
26th Nov 20204:47 pmRNSTransaction in Own Shares
26th Nov 202012:57 pmRNSNet Asset Value(s)
25th Nov 202011:27 amRNSNet Asset Value(s)
24th Nov 202011:55 amRNSNet Asset Value(s)
20th Nov 202011:34 amRNSNet Asset Value(s)
19th Nov 20205:20 pmRNSTransaction in Own Shares
19th Nov 202010:53 amRNSNet Asset Value(s)
18th Nov 202011:55 amRNSNet Asset Value(s)
18th Nov 20207:00 amRNSDividend Declaration
17th Nov 20204:50 pmRNSTransaction in Own Shares
17th Nov 202012:03 pmRNSNet Asset Value(s)
16th Nov 202012:57 pmRNSNet Asset Value(s)
13th Nov 20201:07 pmRNSNet Asset Value(s)
12th Nov 20201:28 pmRNSNet Asset Value(s)
11th Nov 20201:33 pmRNSNet Asset Value(s)
10th Nov 20205:18 pmRNSTransaction in Own Shares
10th Nov 20201:19 pmRNSNet Asset Value(s)
10th Nov 20207:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.